Pansam

# Pansam ## Overview - **Classification**: Novel Broad-Spectrum Antibiotic - **Mechanism**: Inhibits bacterial protein synthesis by binding irreversibly to the bacterial 50S ribosomal subunit, leading to bacterial death. ## Primary Indications 1. **Community-Acquired Pneumonia (CAP)** - Treatment of adults and pediatric patients caused by susceptible organisms. 2. **Complicated Urinary Tract Infections (cUTI)** - Including pyelonephritis, caused by susceptible Gram-negative bacteria. 3. **Acute Bacterial Skin and Skin Structure Infections (ABSSSI)** - Including cellulitis and wound infections. ## Adult Dosing ### Standard Dosing **Community-Acquired Pneumonia (CAP), cUTI, ABSSSI** - **Dose**: **600 mg** - **Frequency**: Once daily (**q24h**) - **Route**: Oral (PO) or Intravenous (IV) - **Duration**: 5-10 days, depending on infection severity and clinical response. ### Dose Adjustments - **Renal Impairment**: - CrCl **30-50 mL/min**: **600 mg q48h** - CrCl **<30 mL/min** (including HD/PD): **300 mg q48h** - Administer after dialysis. - **Hepatic Impairment**: - Mild-Moderate (Child-Pugh A/B): No dose adjustment needed. - Severe (Child-Pugh C): Use with caution; consider **300 mg q24h** and close monitoring. - **Elderly Patients**: No specific dose adjustment needed based on age alone; adjust based on renal function. ## Pediatric Dosing ### Neonates (0-28 days) - **Dose**: Not recommended due to lack of data and potential for developmental toxicity. - **Special Notes**: Use only in life-threatening infections where no alternatives exist, with expert consultation and careful monitoring. ### Infants (1-12 months) - **Dose**: **10 mg/kg/dose** - **Frequency**: Every 12 hours (**q12h**) - **Maximum**: **300 mg/dose** - **Special Notes**: Consider IV route for severe infections. Oral suspension available. ### Children (1-12 years) - **Dose**: **10 mg/kg/dose** - **Frequency**: Every 12 hours (**q12h**) - **Maximum**: **600 mg/dose** - **Special Notes**: Transition to once daily dosing (adult dose) if weight >40 kg. ### Adolescents (13-18 years) - **Dose**: Treat as adult dosing, **600 mg** - **Frequency**: Once daily (**q24h**) - **Maximum**: **600 mg/day** ## Safety Information ### Contraindications - **Absolute**: Hypersensitivity to Pansam or any component. - **Absolute**: Concurrent use with potent **CYP3A4 inducers** (e.g., rifampin, carbamazepine, phenytoin). - **Relative**: History of severe hepatotoxicity with previous antibiotic use. ### Common Adverse Effects - **Very Common (>10%)**: Nausea, Diarrhea, Headache. - **Common (1-10%)**: Vomiting, Abdominal pain, Dizziness, Rash. - **Serious but Rare**: Severe hepatotoxicity (e.g., jaundice, elevated LFTs), Clostridioides difficile-associated diarrhea (CDAD), severe cutaneous adverse reactions (SCARs). ### Key Drug Interactions - **CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir)**: May increase Pansam levels; monitor for toxicity. - **QT-prolonging Drugs (e.g., amiodarone, quinidine)**: Increased risk of QT prolongation; avoid co-administration if possible. - **Warfarin**: May potentiate anticoagulant effect; monitor INR closely. - **Antacids (containing Mg/Al)**: May decrease Pansam absorption; separate administration by at least 2 hours. ## Monitoring & Follow-up - **Before Treatment**: Baseline LFTs (ALT, AST, total bilirubin), renal function (Cr, BUN). - **During Treatment**: Monitor LFTs weekly if treatment >7 days or in patients with hepatic impairment. Monitor for clinical signs of hepatotoxicity or CDAD. - **Clinical Signs**: Watch for yellowing of skin/eyes, dark urine, severe diarrhea, new skin rash. ## Clinical Pearls - 💡 **Tip 1**: Administer Pansam with food to minimize GI upset, though it can be taken without. - 💡 **Tip 2**: Ensure adequate hydration during treatment to prevent potential renal complications. - 💡 **Tip 3**: Counsel patients to complete the full course of therapy, even if symptoms improve, to prevent resistance. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.